Medical - Healthcare Information Services
Compare Stocks
4 / 10Stock Comparison
SY vs ISRG vs SYK vs MTCH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
Medical - Devices
Internet Content & Information
SY vs ISRG vs SYK vs MTCH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Instruments & Supplies | Medical - Devices | Internet Content & Information |
| Market Cap | $198M | $161.07B | $112.69B | $8.34B |
| Revenue (TTM) | $1.43B | $10.58B | $25.12B | $3.52B |
| Net Income (TTM) | $-741M | $2.98B | $3.25B | $663M |
| Gross Margin | 51.6% | 66.3% | 63.5% | 73.8% |
| Operating Margin | -53.2% | 30.5% | 22.4% | 26.6% |
| Forward P/E | — | 43.8x | 19.6x | 13.5x |
| Total Debt | $240M | $303M | $14.86B | $3.97B |
| Cash & Equiv. | $588M | $3.37B | $4.01B | $1.03B |
SY vs ISRG vs SYK vs MTCH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| So-Young Internatio… (SY) | 100 | 32.6 | -67.4% |
| Intuitive Surgical,… (ISRG) | 100 | 234.6 | +134.6% |
| Stryker Corporation (SYK) | 100 | 150.3 | +50.3% |
| Match Group, Inc. (MTCH) | 100 | 40.2 | -59.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SY vs ISRG vs SYK vs MTCH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SY is the clearest fit if your priority is momentum.
- +266.1% vs SYK's -22.5%
ISRG has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
- 5.5% 10Y total return vs SYK's 187.1%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
- 20.5% revenue growth vs SY's -2.1%
SYK is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 34 yrs, beta 0.55, yield 1.1%
- Beta 0.55, yield 1.1%, current ratio 1.89x
- Beta 0.55 vs SY's 2.05
- 1.1% yield, 34-year raise streak, vs MTCH's 2.0%, (1 stock pays no dividend)
MTCH is the clearest fit if your priority is valuation efficiency.
- PEG 0.46 vs ISRG's 2.01
- Lower P/E (13.5x vs 19.6x), PEG 0.46 vs 1.32
- 15.3% ROA vs SY's -28.0%, ROIC 23.7% vs -24.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs SY's -2.1% | |
| Value | Lower P/E (13.5x vs 19.6x), PEG 0.46 vs 1.32 | |
| Quality / Margins | 28.2% margin vs SY's -51.8% | |
| Stability / Safety | Beta 0.55 vs SY's 2.05 | |
| Dividends | 1.1% yield, 34-year raise streak, vs MTCH's 2.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +266.1% vs SYK's -22.5% | |
| Efficiency (ROA) | 15.3% ROA vs SY's -28.0%, ROIC 23.7% vs -24.1% |
SY vs ISRG vs SYK vs MTCH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SY vs ISRG vs SYK vs MTCH — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 2 of 6 categories
MTCH leads 2 • SY leads 0 • SYK leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SYK is the larger business by revenue, generating $25.1B annually — 17.5x SY's $1.4B. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to SY's -51.8%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.4B | $10.6B | $25.1B | $3.5B |
| EBITDAEarnings before interest/tax | -$751M | $3.8B | $6.3B | $1.0B |
| Net IncomeAfter-tax profit | -$741M | $3.0B | $3.2B | $663M |
| Free Cash FlowCash after capex | $0 | $2.8B | $4.3B | $1.0B |
| Gross MarginGross profit ÷ Revenue | +51.6% | +66.3% | +63.5% | +73.8% |
| Operating MarginEBIT ÷ Revenue | -53.2% | +30.5% | +22.4% | +26.6% |
| Net MarginNet income ÷ Revenue | -51.8% | +28.2% | +12.9% | +18.8% |
| FCF MarginFCF ÷ Revenue | -6.0% | +26.8% | +17.1% | +29.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.0% | +23.0% | +11.4% | +3.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.3% | +18.8% | +56.0% | +45.5% |
Valuation Metrics
MTCH leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 15.1x trailing earnings, MTCH trades at a 74% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), MTCH offers better value at 0.51x vs ISRG's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $198M | $161.1B | $112.7B | $8.3B |
| Enterprise ValueMkt cap + debt − cash | $147M | $158.0B | $123.5B | $11.3B |
| Trailing P/EPrice ÷ TTM EPS | -4.68x | 57.62x | 35.03x | 15.05x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 43.84x | 19.62x | 13.49x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.65x | 2.36x | 0.51x |
| EV / EBITDAEnterprise value multiple | — | 43.62x | 20.31x | 11.53x |
| Price / SalesMarket cap ÷ Revenue | 0.92x | 16.00x | 4.49x | 2.39x |
| Price / BookPrice ÷ Book value/share | 1.41x | 9.17x | 5.02x | — |
| Price / FCFMarket cap ÷ FCF | — | 64.67x | 26.31x | 8.14x |
Profitability & Efficiency
MTCH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for SY. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SYK's 0.66x. On the Piotroski fundamental quality scale (0–9), MTCH scores 7/9 vs SY's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -41.4% | +16.9% | +15.0% | — |
| ROA (TTM)Return on assets | -28.0% | +14.8% | +6.9% | +15.3% |
| ROICReturn on invested capital | -24.1% | +15.0% | +11.4% | +23.7% |
| ROCEReturn on capital employed | -26.1% | +16.5% | +13.0% | +23.7% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.12x | 0.02x | 0.66x | — |
| Net DebtTotal debt minus cash | -$348M | -$3.1B | $10.8B | $2.9B |
| Cash & Equiv.Liquid assets | $588M | $3.4B | $4.0B | $1.0B |
| Total DebtShort + long-term debt | $240M | $303M | $14.9B | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | — | — | 6.72x | 6.17x |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $2,530 for MTCH. Over the past 12 months, SY leads with a +266.1% total return vs SYK's -22.5%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs SYK's 1.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +13.1% | -19.3% | -15.2% | +14.1% |
| 1-Year ReturnPast 12 months | +266.1% | -15.4% | -22.5% | +20.5% |
| 3-Year ReturnCumulative with dividends | +11.3% | +49.6% | +5.5% | +13.9% |
| 5-Year ReturnCumulative with dividends | -64.7% | +58.7% | +21.5% | -74.7% |
| 10-Year ReturnCumulative with dividends | -82.9% | +554.2% | +187.1% | +195.5% |
| CAGR (3Y)Annualised 3-year return | +3.6% | +14.4% | +1.8% | +4.4% |
Risk & Volatility
Evenly matched — SYK and MTCH each lead in 1 of 2 comparable metrics.
Risk & Volatility
SYK is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than SY's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MTCH currently trades 91.4% from its 52-week high vs SY's 48.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.05x | 1.02x | 0.55x | 1.04x |
| 52-Week HighHighest price in past year | $6.28 | $603.88 | $404.87 | $39.20 |
| 52-Week LowLowest price in past year | $0.80 | $427.84 | $289.91 | $26.80 |
| % of 52W HighCurrent price vs 52-week peak | +48.1% | +75.1% | +72.7% | +91.4% |
| RSI (14)Momentum oscillator 0–100 | 65.7 | 42.4 | 24.3 | 68.8 |
| Avg Volume (50D)Average daily shares traded | 457K | 1.8M | 2.1M | 4.4M |
Analyst Outlook
Evenly matched — SYK and MTCH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SY as "Buy", ISRG as "Buy", SYK as "Buy", MTCH as "Buy". Consensus price targets imply 37.3% upside for ISRG (target: $623) vs -73.5% for SY (target: $1). For income investors, MTCH offers the higher dividend yield at 1.98% vs SYK's 1.14%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $0.80 | $622.60 | $403.69 | $36.00 |
| # AnalystsCovering analysts | 5 | 55 | 50 | 32 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | — | +1.1% | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | — | 34 | 1 |
| Dividend / ShareAnnual DPS | $0.32 | — | $3.36 | $0.71 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +1.4% | 0.0% | +9.5% |
ISRG leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MTCH leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
SY vs ISRG vs SYK vs MTCH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SY or ISRG or SYK or MTCH a better buy right now?
For growth investors, Intuitive Surgical, Inc.
(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -2. 1% for So-Young International Inc. (SY). Match Group, Inc. (MTCH) offers the better valuation at 15. 1x trailing P/E (13. 5x forward), making it the more compelling value choice. Analysts rate So-Young International Inc. (SY) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SY or ISRG or SYK or MTCH?
On trailing P/E, Match Group, Inc.
(MTCH) is the cheapest at 15. 1x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Match Group, Inc. is actually cheaper at 13. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Match Group, Inc. wins at 0. 46x versus Intuitive Surgical, Inc. 's 2. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SY or ISRG or SYK or MTCH?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +58. 7%, compared to -74. 7% for Match Group, Inc. (MTCH). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus SY's -82. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SY or ISRG or SYK or MTCH?
By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.
55β versus So-Young International Inc. 's 2. 05β — meaning SY is approximately 275% more volatile than SYK relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 66% for Stryker Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SY or ISRG or SYK or MTCH?
By revenue growth (latest reported year), Intuitive Surgical, Inc.
(ISRG) is pulling ahead at 20. 5% versus -2. 1% for So-Young International Inc. (SY). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -28. 4% for So-Young International Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SY or ISRG or SYK or MTCH?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -40. 2% for So-Young International Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -42. 6% for SY. At the gross margin level — before operating expenses — MTCH leads at 72. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SY or ISRG or SYK or MTCH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Match Group, Inc. (MTCH) is the more undervalued stock at a PEG of 0. 46x versus Intuitive Surgical, Inc. 's 2. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Match Group, Inc. (MTCH) trades at 13. 5x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 30. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 3% to $622. 60.
08Which pays a better dividend — SY or ISRG or SYK or MTCH?
In this comparison, MTCH (2.
0% yield), SY (1. 6% yield), SYK (1. 1% yield) pay a dividend. ISRG does not pay a meaningful dividend and should not be held primarily for income.
09Is SY or ISRG or SYK or MTCH better for a retirement portfolio?
For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
55), 1. 1% yield, +187. 1% 10Y return). So-Young International Inc. (SY) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SYK: +187. 1%, SY: -82. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SY and ISRG and SYK and MTCH?
These companies operate in different sectors (SY (Healthcare) and ISRG (Healthcare) and SYK (Healthcare) and MTCH (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SY is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock; MTCH is a small-cap deep-value stock. SY, SYK, MTCH pay a dividend while ISRG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Net Margin > 11%
- Dividend Yield > 0.7%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.